Trial Profile
Clinical Trials Insight: 700030113
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2008
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary)
- Indications Graft-versus-host disease
- Focus Registrational; Therapeutic Use
- Sponsors Biovest International
- 25 Jan 2008 New trial record.